U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Securing a prescription for GLP-1s can be pricey — and not to mention, sometimes quite frustrating and invasive. But safety ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...

Ahead of a Senate hearing centered on high prices for Novo Nordisk’s in-demand semaglutide medications, lawmakers are ...

both Sun Pharma and Mylan have filed Abbreviated New Drug Applications with the U.S. Food and Drug Administration for approval of generic versions of Wegovy, a semaglutide injection that improves ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

The active ingredient in Wegovy goes by the chemical name semaglutide. The first place an expiring patent will allow generic ...

Semaglutide is a generic medication. Its brand names are approved for the treatment of type 2 diabetes and obesity. Compounded semaglutide is not FDA-approved, could come with risks, and may lead ...

Senator Bernie Sanders reveals that generic drug manufacturers can sell semaglutide, the generic of Ozempic & Wegovy, for less than $100 a month.

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Compounded semaglutide is not a generic alternative to these drugs. More often, compounded drugs are tailored specifically ...

Swiss pharmaceutical company Sandoz is launching a generic semaglutide, the main ingredient of Ozempic, in the U.S. when the market opens in 2030, Bloomberg reported Sept. 3. The company first ...